- Tumor necrosis factor alpha inhibitors or interleukin 17 inhibitors in the treatment of patients with axial spondyloarthritis2019 | First Faculty of Medicine
- Interleukin 17A inhibition is the effective therapeutic possibility in psoriatic arthritis. Comment to FUTIURE 5 study2018 | Faculty of Medicine in Hradec Králové
- Long‑term effect and safety of secukinumab in the therapy of ankylosing spondylitis – a case study2023 | First Faculty of Medicine
- Advances in biological therapy for psoriasis2017 | First Faculty of Medicine
- Inhibition of IL-17 - a new approach in the biological treatment of spondyloarthritides2017 | First Faculty of Medicine
- Secukinumab in treating psoriatic arthritis2017 | First Faculty of Medicine
- Efficacy of switches within the class of IL-17 inhibitors: An analysis of data from the Czech nationwide registry of psoriatic patients receiving biological/targeted therapy (BIOREP)2022 | First Faculty of Medicine, Third Faculty of Medicine, Central Library of Charles University, Faculty of Medicine in Pilsen
- Management of psoriatic disease with anti IL-17 and anti-IL-23 monoclonal antibodies2022 | Faculty of Medicine in Hradec Králové
- Hidradenitis suppurativa2022 | Third Faculty of Medicine
- Secukinumab in the treatment of ankylosing spondylitis2019 | First Faculty of Medicine
- Is it possible to modify structural progression in patients with axial spondyloarthritis?2019 | First Faculty of Medicine
- Current overview of available products for biologic therapy of psoriasis2019 | Third Faculty of Medicine
- Axial spondyloarthritis: Early diagnosis helps initiate effective treatment2018 | First Faculty of Medicine
- ASAS‑EULAR recommendations for the treatment of axial spondylarthritis: an update2023 | First Faculty of Medicine
- Psoriasis Treatment with Adalimumab in Clinical Practice: Long Tenn Experience of a Center for Biological Therapy of Psoriasis2015 | Third Faculty of Medicine
- Ustekinutab in the treatment of psoriasis2017 | Publication without faculty affiliation
- ABD-Derived Protein Blockers of Human IL-17 Receptor A as Non-IgG Alternatives for Modulation of IL-17-Dependent Pro-Inflammatory Axis2018 | Central Library of Charles University